The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Issazadeh, S.
Right arrow Articles by Khoury, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Issazadeh, S.
Right arrow Articles by Khoury, S. J.
The Journal of Immunology, 1999, 162: 761-765.
Copyright © 1999 by The American Association of Immunologists

Acquired Thymic Tolerance: Role of CTLA4 in the Initiation and Maintenance of Tolerance in a Clinically Relevant Autoimmune Disease Model1

Shohreh Issazadeh*, ManHua Zhang*, Mohamed H. Sayegh{dagger} and Samia J. Khoury2,*

* Center for Neurologic Diseases, and {dagger} Laboratory of Immunogenetics and Transplantation, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115

Injection of Ag into the thymus of adult animals induces specific systemic tolerance. The mechanisms of acquired thymic tolerance include anergy and the deletion of Ag-specific T cells. Here, we report that anergy to nominal Ag induced via acquired thymic tolerance requires CTL-associated Ag 4 (CTLA4) engagement. The role of CTLA4 in the induction and maintenance of tolerance was then investigated in the murine experimental autoimmune encephalomyelitis model. CTLA4 blockade abrogated the induction but not the maintenance phase of acquired thymic tolerance induced by intrathymic injection of myelin Ags. In addition, CTLA4 blockade had a restricted window of action after priming with Ag, which is consistent with the expression patterns of CTLA4 in vivo. We conclude that: 1) the induction of acquired thymic tolerance requires signaling through CTLA4 and 2) CTLA4 does not appear to be required for the maintenance of acquired thymic tolerance. This is the first report documenting the role of a CTLA4 negative signaling pathway in the induction of tolerance in an autoimmune disease model.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. M. Gorczynski, Z. Chen, W. He, I. Khatri, Y. Sun, K. Yu, and I. Boudakov
Expression of a CD200 Transgene Is Necessary for Induction but Not Maintenance of Tolerance to Cardiac and Skin Allografts
J. Immunol., August 1, 2009; 183(3): 1560 - 1568.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Song, Z. Guan, I. E. Gienapp, T. Shawler, J. Benson, and C. C. Whitacre
The Thymus Plays a Role in Oral Tolerance in Experimental Autoimmune Encephalomyelitis
J. Immunol., August 1, 2006; 177(3): 1500 - 1509.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Homann, W. Dummer, T. Wolfe, E. Rodrigo, A. N. Theofilopoulos, M. B. A. Oldstone, and M. G. von Herrath
Lack of Intrinsic CTLA-4 Expression Has Minimal Effect on Regulation of Antiviral T-Cell Immunity
J. Virol., January 1, 2006; 80(1): 270 - 280.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. P. Treschow, J. Backlund, R. Holmdahl, and S. Issazadeh-Navikas
Intrinsic Tolerance in Autologous Collagen-Induced Arthritis Is Generated by CD152-Dependent CD4+ Suppressor Cells
J. Immunol., June 1, 2005; 174(11): 6742 - 6750.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. D. Salama, T. Chitnis, J. Imitola, M. J. I. Ansari, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury
Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis
J. Exp. Med., July 7, 2003; 198(1): 71 - 78.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sho, A. Yamada, N. Najafian, A. D. Salama, H. Harada, S. E. Sandner, A. Sanchez-Fueyo, X. X. Zheng, T. B. Strom, and M. H. Sayegh
Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size
J. Immunol., October 1, 2002; 169(7): 3744 - 3751.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Kinjo, N. Takasu, I. Komiya, T. Tomoyose, M. Takara, T. Kouki, Y. Shimajiri, K. Yabiku, and H. Yoshimura
Remission of Graves' Hyperthyroidism and A/G Polymorphism at Position 49 in Exon 1 of Cytotoxic T Lymphocyte-Associated Molecule-4 Gene
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2593 - 2596.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X.-F. Bai, J. Liu, K. F. May Jr, Y. Guo, P. Zheng, and Y. Liu
B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo
Blood, April 15, 2002; 99(8): 2880 - 2889.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Yamada, A. D. Salama, and M. H. Sayegh
The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 559 - 575.
[Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Frauwirth, M.-L. Alegre, and C. B. Thompson
CTLA-4 Is Not Required for Induction of CD8+ T Cell Anergy In Vivo
J. Immunol., November 1, 2001; 167(9): 4936 - 4941.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Yamada, K. Kishimoto, V. M. Dong, M. Sho, A. D. Salama, N. G. Anosova, G. Benichou, D. A. Mandelbrot, A. H. Sharpe, L. A. Turka, et al.
CD28-independent Costimulation of T Cells in Alloimmune Responses
J. Immunol., July 1, 2001; 167(1): 140 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. D. Griffin, D. K. Hong, P. O. Holman, K.-M. Lee, M. J. Whitters, S. M. O'Herrin, F. Fallarino, M. Collins, D. M. Segal, T. F. Gajewski, et al.
Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152)
J. Immunol., May 1, 2000; 164(9): 4433 - 4442.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Frauwirth, M.-L. Alegre, and C. B. Thompson
Induction of T Cell Anergy in the Absence of CTLA-4/B7 Interaction
J. Immunol., March 15, 2000; 164(6): 2987 - 2993.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. B. Ratts, L. R. Arredondo, P. Bittner, P. J. Perrin, A. E. Lovett-Racke, and M. K. Racke
The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.p. antigen administration
Int. Immunol., December 1, 1999; 11(12): 1881 - 1888.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. B. Ratts, L. R. Arredondo, P. Bittner, P. J. Perrin, A. E. Lovett-Racke, and M. K. Racke
The role of CTLA-4 in tolerance induction and Ttigen administration cell differentiation in experimental autoimmune encephalomyelitis: i.v. antigen administration
Int. Immunol., December 1, 1999; 11(12): 1889 - 1896.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Luhder, C. Chambers, J. P. Allison, C. Benoist, and D. Mathis
Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells
PNAS, October 24, 2000; 97(22): 12204 - 12209.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.